Haleon plc (HLN.L) LSE

Currency In GBp

AD

Haleon plc

Address

Building 5

Weybridge, KT13 0NY

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 1932 822000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

24561

First IPO Date

July 18, 2022

Key Executives

NameTitlePayYear Born
Brian James McNamaraChief Executive Officer & Executive Director2.86M1966
Dawn Amanda AllenChief Financial Officer & Director1.54M1968
Adrian Charles MorrisGeneral Counsel01967
Tamara RogersChief Marketing Officer01968
Bjorn TimelinHead of Strategy0N/A
Filippo LanziPresident of EMEA & LatAm0N/A
Line De DeckerChief Human Resources Officer01974
Keith ChoyPresident of Asia Pacific01969
Claire DicksonChief Digital & Technology Officer0N/A
Joanne RussellHead of Investor Relations0N/A
AD

Description

Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.

AD